Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLORY: Insulin glargine versus metformin as first-line therapy in early type 2 diabetes
2008-006860-12Phase 4Completed
- Sponsor
- GWT-TUD
- Start
- Nov 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Insulin glargine arm with Metformin arm (2 arms). Primary endpoint: Postprandial glucose AUC change at 36 weeks. Started Nov 2008; status: completed.
02
Drugs
insulin glarginemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-006860-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006860-12.